Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Assessment of Potential Cocaine Pharmacotherapies in Monkeys.
Date: April 23, 2008.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Courtyard by Marriott Rockville, 2500 Research Boulevard, Rockville, MD 20850.
Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401, (301) 435-1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)Start Signature
Dated: March 20, 2008.
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-6329 Filed 3-28-08; 8:45 am]
BILLING CODE 4140-01-M